Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements
Ushering more targeted therapies into the 2024 updates to the NCCN Clinical Practice Guidelines in Oncology for biliary tract cancers represented a notable advancement in the gastrointestinal (GI) cancer space, and new guideline specifications are coming …